 | • レポートコード：D005-00150 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がんゲノムシーケンスの世界市場を広く調査・分析し、今後の市場展望をまとめております。がんゲノムシーケンスの種類別市場規模（二世代、三世代）、用途別市場規模（治療、研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Agilent Technologies、Hamilton Thorne Biosciences、LI-COR Biosciences、GE Healthcare Life Sciences、Bayer、Johnson & Johnson、Microchip Biotechnologies、Beckman Coulter、Abbott Laboratories、Integrated DNA Technologies、Myriad Genetics、Pacific Biosciences、Commonwealth Biotechnologies、ZS Genetics ・地域別グローバル市場分析 2015年-2020年 ・がんゲノムシーケンスの北米市場（アメリカ、カナダ、メキシコ） ・がんゲノムシーケンスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がんゲノムシーケンスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がんゲノムシーケンスの南米市場（ブラジル、アルゼンチン） ・がんゲノムシーケンスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：二世代、三世代 ・用途別分析：治療、研究 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Genome Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Genome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Genome Sequencing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Genome Sequencing market has been segmented into:
Second generation
Third generation
By Application, Cancer Genome Sequencing has been segmented into:
Treatment
Research
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Genome Sequencing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Genome Sequencing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Genome Sequencing market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Genome Sequencing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Genome Sequencing Market Share Analysis
Cancer Genome Sequencing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Genome Sequencing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Genome Sequencing sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Genome Sequencing are:
Agilent Technologies
Hamilton Thorne Biosciences
LI-COR Biosciences
GE Healthcare Life Sciences
Bayer
Johnson & Johnson
Microchip Biotechnologies
Beckman Coulter
Abbott Laboratories
Integrated DNA Technologies
Myriad Genetics
Pacific Biosciences
Commonwealth Biotechnologies
ZS Genetics
Table of Contents
1 Cancer Genome Sequencing Market Overview
1.1 Product Overview and Scope of Cancer Genome Sequencing
1.2 Classification of Cancer Genome Sequencing by Type
1.2.1 Global Cancer Genome Sequencing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Genome Sequencing Revenue Market Share by Type in 2019
1.2.3 Second generation
1.2.4 Third generation
1.3 Global Cancer Genome Sequencing Market by Application
1.3.1 Overview: Global Cancer Genome Sequencing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Treatment
1.3.3 Research
1.4 Global Cancer Genome Sequencing Market by Regions
1.4.1 Global Cancer Genome Sequencing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Genome Sequencing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Genome Sequencing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Genome Sequencing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Genome Sequencing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Genome Sequencing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Genome Sequencing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agilent Technologies SWOT Analysis
2.1.4 Agilent Technologies Product and Services
2.1.5 Agilent Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hamilton Thorne Biosciences
2.2.1 Hamilton Thorne Biosciences Details
2.2.2 Hamilton Thorne Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hamilton Thorne Biosciences SWOT Analysis
2.2.4 Hamilton Thorne Biosciences Product and Services
2.2.5 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.3 LI-COR Biosciences
2.3.1 LI-COR Biosciences Details
2.3.2 LI-COR Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LI-COR Biosciences SWOT Analysis
2.3.4 LI-COR Biosciences Product and Services
2.3.5 LI-COR Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.4 GE Healthcare Life Sciences
2.4.1 GE Healthcare Life Sciences Details
2.4.2 GE Healthcare Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GE Healthcare Life Sciences SWOT Analysis
2.4.4 GE Healthcare Life Sciences Product and Services
2.4.5 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer SWOT Analysis
2.5.4 Bayer Product and Services
2.5.5 Bayer Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Microchip Biotechnologies
2.7.1 Microchip Biotechnologies Details
2.7.2 Microchip Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Microchip Biotechnologies SWOT Analysis
2.7.4 Microchip Biotechnologies Product and Services
2.7.5 Microchip Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beckman Coulter
2.8.1 Beckman Coulter Details
2.8.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beckman Coulter SWOT Analysis
2.8.4 Beckman Coulter Product and Services
2.8.5 Beckman Coulter Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott Laboratories SWOT Analysis
2.9.4 Abbott Laboratories Product and Services
2.9.5 Abbott Laboratories Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Integrated DNA Technologies
2.10.1 Integrated DNA Technologies Details
2.10.2 Integrated DNA Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Integrated DNA Technologies SWOT Analysis
2.10.4 Integrated DNA Technologies Product and Services
2.10.5 Integrated DNA Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Myriad Genetics
2.11.1 Myriad Genetics Details
2.11.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Myriad Genetics SWOT Analysis
2.11.4 Myriad Genetics Product and Services
2.11.5 Myriad Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pacific Biosciences
2.12.1 Pacific Biosciences Details
2.12.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pacific Biosciences SWOT Analysis
2.12.4 Pacific Biosciences Product and Services
2.12.5 Pacific Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Commonwealth Biotechnologies
2.13.1 Commonwealth Biotechnologies Details
2.13.2 Commonwealth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Commonwealth Biotechnologies SWOT Analysis
2.13.4 Commonwealth Biotechnologies Product and Services
2.13.5 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.14 ZS Genetics
2.14.1 ZS Genetics Details
2.14.2 ZS Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ZS Genetics SWOT Analysis
2.14.4 ZS Genetics Product and Services
2.14.5 ZS Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Genome Sequencing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Genome Sequencing Players Market Share
3.2.2 Top 10 Cancer Genome Sequencing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Genome Sequencing Revenue and Market Share by Regions
4.2 North America Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
5 North America Cancer Genome Sequencing Revenue by Countries
5.1 North America Cancer Genome Sequencing Revenue by Countries (2015-2020)
5.2 USA Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
6 Europe Cancer Genome Sequencing Revenue by Countries
6.1 Europe Cancer Genome Sequencing Revenue by Countries (2015-2020)
6.2 Germany Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
6.4 France Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Genome Sequencing Revenue by Countries
7.1 Asia-Pacific Cancer Genome Sequencing Revenue by Countries (2015-2020)
7.2 China Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
7.5 India Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
8 South America Cancer Genome Sequencing Revenue by Countries
8.1 South America Cancer Genome Sequencing Revenue by Countries (2015-2020)
8.2 Brazil Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Genome Sequencing by Countries
9.1 Middle East & Africa Cancer Genome Sequencing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Genome Sequencing Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Genome Sequencing Market Forecast by Type (2019-2024)
10.3 Second generation Revenue Growth Rate (2015-2025)
10.4 Third generation Revenue Growth Rate (2015-2025)
11 Global Cancer Genome Sequencing Market Segment by Application
11.1 Global Cancer Genome Sequencing Revenue Market Share by Application (2015-2020)
11.2 Cancer Genome Sequencing Market Forecast by Application (2019-2024)
11.3 Treatment Revenue Growth (2015-2020)
11.4 Research Revenue Growth (2015-2020)
12 Global Cancer Genome Sequencing Market Size Forecast (2021-2025)
12.1 Global Cancer Genome Sequencing Market Size Forecast (2021-2025)
12.2 Global Cancer Genome Sequencing Market Forecast by Regions (2021-2025)
12.3 North America Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
12.6 South America Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Genome Sequencing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Genome Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Genome Sequencing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Genome Sequencing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Agilent Technologies Corporate Information, Location and Competitors
Table 6. Agilent Technologies Cancer Genome Sequencing Major Business
Table 7. Agilent Technologies Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 8. Agilent Technologies SWOT Analysis
Table 9. Agilent Technologies Cancer Genome Sequencing Product and Solutions
Table 10. Agilent Technologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Hamilton Thorne Biosciences Corporate Information, Location and Competitors
Table 12. Hamilton Thorne Biosciences Cancer Genome Sequencing Major Business
Table 13. Hamilton Thorne Biosciences Cancer Genome Sequencing Total Revenue (USD Million) (2018-2019)
Table 14. Hamilton Thorne Biosciences SWOT Analysis
Table 15. Hamilton Thorne Biosciences Cancer Genome Sequencing Product and Solutions
Table 16. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. LI-COR Biosciences Corporate Information, Location and Competitors
Table 18. LI-COR Biosciences Cancer Genome Sequencing Major Business
Table 19. LI-COR Biosciences Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 20. LI-COR Biosciences SWOT Analysis
Table 21. LI-COR Biosciences Cancer Genome Sequencing Product and Solutions
Table 22. LI-COR Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GE Healthcare Life Sciences Corporate Information, Location and Competitors
Table 24. GE Healthcare Life Sciences Cancer Genome Sequencing Major Business
Table 25. GE Healthcare Life Sciences Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 26. GE Healthcare Life Sciences SWOT Analysis
Table 27. GE Healthcare Life Sciences Cancer Genome Sequencing Product and Solutions
Table 28. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bayer Corporate Information, Location and Competitors
Table 30. Bayer Cancer Genome Sequencing Major Business
Table 31. Bayer Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 32. Bayer SWOT Analysis
Table 33. Bayer Cancer Genome Sequencing Product and Solutions
Table 34. Bayer Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Cancer Genome Sequencing Major Business
Table 37. Johnson & Johnson Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Cancer Genome Sequencing Product and Solutions
Table 40. Johnson & Johnson Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Microchip Biotechnologies Corporate Information, Location and Competitors
Table 42. Microchip Biotechnologies Cancer Genome Sequencing Major Business
Table 43. Microchip Biotechnologies Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 44. Microchip Biotechnologies SWOT Analysis
Table 45. Microchip Biotechnologies Cancer Genome Sequencing Product and Solutions
Table 46. Microchip Biotechnologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beckman Coulter Corporate Information, Location and Competitors
Table 48. Beckman Coulter Cancer Genome Sequencing Major Business
Table 49. Beckman Coulter Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 50. Beckman Coulter SWOT Analysis
Table 51. Beckman Coulter Cancer Genome Sequencing Product and Solutions
Table 52. Beckman Coulter Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Laboratories Corporate Information, Location and Competitors
Table 54. Abbott Laboratories Cancer Genome Sequencing Major Business
Table 55. Abbott Laboratories Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 56. Abbott Laboratories SWOT Analysis
Table 57. Abbott Laboratories Cancer Genome Sequencing Product and Solutions
Table 58. Abbott Laboratories Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Integrated DNA Technologies Corporate Information, Location and Competitors
Table 60. Integrated DNA Technologies Cancer Genome Sequencing Major Business
Table 61. Integrated DNA Technologies Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 62. Integrated DNA Technologies SWOT Analysis
Table 63. Integrated DNA Technologies Cancer Genome Sequencing Product and Solutions
Table 64. Integrated DNA Technologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Myriad Genetics Corporate Information, Location and Competitors
Table 66. Myriad Genetics Cancer Genome Sequencing Major Business
Table 67. Myriad Genetics Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 68. Myriad Genetics SWOT Analysis
Table 69. Myriad Genetics Cancer Genome Sequencing Product and Solutions
Table 70. Myriad Genetics Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Pacific Biosciences Corporate Information, Location and Competitors
Table 72. Pacific Biosciences Cancer Genome Sequencing Major Business
Table 73. Pacific Biosciences Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 74. Pacific Biosciences SWOT Analysis
Table 75. Pacific Biosciences Cancer Genome Sequencing Product and Solutions
Table 76. Pacific Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Commonwealth Biotechnologies Corporate Information, Location and Competitors
Table 78. Commonwealth Biotechnologies Cancer Genome Sequencing Major Business
Table 79. Commonwealth Biotechnologies Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 80. Commonwealth Biotechnologies SWOT Analysis
Table 81. Commonwealth Biotechnologies Cancer Genome Sequencing Product and Solutions
Table 82. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. ZS Genetics Corporate Information, Location and Competitors
Table 84. ZS Genetics Cancer Genome Sequencing Major Business
Table 85. ZS Genetics Cancer Genome Sequencing Total Revenue (USD Million) (2017-2018)
Table 86. ZS Genetics SWOT Analysis
Table 87. ZS Genetics Cancer Genome Sequencing Product and Solutions
Table 88. ZS Genetics Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Cancer Genome Sequencing Revenue (Million USD) by Players (2015-2020)
Table 90. Global Cancer Genome Sequencing Revenue Share by Players (2015-2020)
Table 91. Global Cancer Genome Sequencing Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Cancer Genome Sequencing Revenue Market Share by Regions (2015-2020)
Table 93. North America Cancer Genome Sequencing Revenue by Countries (2015-2020)
Table 94. North America Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Table 95. Europe Cancer Genome Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Cancer Genome Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Cancer Genome Sequencing Revenue by Countries (2015-2020)
Table 98. South America Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Cancer Genome Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Table 101. Global Cancer Genome Sequencing Revenue (Million USD) by Type (2015-2020)
Table 102. Global Cancer Genome Sequencing Revenue Share by Type (2015-2020)
Table 103. Global Cancer Genome Sequencing Revenue Forecast by Type (2021-2025)
Table 104. Global Cancer Genome Sequencing Revenue by Application (2015-2020)
Table 105. Global Cancer Genome Sequencing Revenue Share by Application (2015-2020)
Table 106. Global Cancer Genome Sequencing Revenue Forecast by Application (2021-2025)
Table 107. Global Cancer Genome Sequencing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Genome Sequencing Picture
Figure 2. Global Cancer Genome Sequencing Revenue Market Share by Type in 2019
Figure 3. Second generation Picture
Figure 4. Third generation Picture
Figure 5. Cancer Genome Sequencing Revenue Market Share by Application in 2019
Figure 6. Treatment Picture
Figure 7. Research Picture
Figure 8. Global Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Cancer Genome Sequencing Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Cancer Genome Sequencing Revenue Market Share in 2019
Figure 17. Global Top 10 Players Cancer Genome Sequencing Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Cancer Genome Sequencing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Cancer Genome Sequencing Revenue Market Share by Regions (2015-2020)
Figure 21. Global Cancer Genome Sequencing Revenue Market Share by Regions in 2018
Figure 22. North America Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 23. Europe Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 25. South America Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 27. North America Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Figure 28. North America Cancer Genome Sequencing Revenue Market Share by Countries in 2019
Figure 29. USA Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 30. Canada Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 32. Europe Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Cancer Genome Sequencing Revenue Market Share by Countries in 2019
Figure 34. Germany Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 35. UK Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 36. France Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 37. Russia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 38. Italy Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Cancer Genome Sequencing Revenue Market Share by Countries in 2019
Figure 41. China Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 42. Japan Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 43. Korea Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 44. India Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 46. South America Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Figure 47. South America Cancer Genome Sequencing Revenue Market Share by Countries in 2019
Figure 48. Brazil Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Cancer Genome Sequencing Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Cancer Genome Sequencing Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 53. UAE Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Cancer Genome Sequencing Revenue and Growth Rate (2015-2020)
Figure 56. Global Cancer Genome Sequencing Revenue Share by Type (2015-2020)
Figure 57. Global Cancer Genome Sequencing Revenue Share by Type in 2019
Figure 58. Global Cancer Genome Sequencing Market Share Forecast by Type (2021-2025)
Figure 59. Global Second generation Revenue Growth Rate (2015-2020)
Figure 60. Global Third generation Revenue Growth Rate (2015-2020)
Figure 61. Global Cancer Genome Sequencing Revenue Share by Application (2015-2020)
Figure 62. Global Cancer Genome Sequencing Revenue Share by Application in 2019
Figure 63. Global Cancer Genome Sequencing Market Share Forecast by Application (2021-2025)
Figure 64. Global Treatment Revenue Growth Rate (2015-2020)
Figure 65. Global Research Revenue Growth Rate (2015-2020)
Figure 66. Global Cancer Genome Sequencing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Cancer Genome Sequencing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Cancer Genome Sequencing Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
Figure 70. Europe Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
Figure 72. South America Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Cancer Genome Sequencing Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
単一細胞ゲノム配列決定の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Single-Cell Genome Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1180.6 million by 2025, from USD 870.3 million in 2019. The Single-…- 次世代シーケンシングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Next-Generation Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Next-Generation Se…
- がん腫瘍プロファイリングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Tumor Profiling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 54970 million by 2025, from USD 37570 million in 2019. The Cancer Tumor P…
- 次世代シーケンス（NGS）サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Next-Generation Sequencing (NGS) Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 15.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1870.1 million by 2025, from USD 1039.4 million in 201…
- 次世代がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Next Generation Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.7% in the forecast period of 2020 to 2025 and will expected to reach USD 10560 million by 2025, from USD 5506.2 million in 2019. The N…